Almac and Exco InTouch Form Alliance to Deliver Patient Compliance and ePRO Services Using Multiple Technologies

SOUDERTON, Pennsylvania, March 21, 2011 - The Almac Group and Exco InTouch announced today that Almac's Clinical
Technologies business unit, the leading provider of IXRS(R) (Interactive
Voice and Web Response) services relating to patient and drug supply
management, has formed an exclusive integrated patient management alliance
with Exco InTouch, an innovative firm specializing in patient recruitment,
retention, compliance and ePRO services. The alliance will be focused on the
integration of both technology and processes by both firms to deliver patient
management, compliance, retention, and ePRO service offerings to sponsors of
clinical trials.

The Almac-Exco InTouch offering serves a pressing need in the drug
development process: Engaging, retaining, and enhancing compliance of
patients from the earliest stages of recruitment and throughout the course of
a trial. Exco InTouch will work with Almac to seamlessly integrate its market
leading retention and compliance technology solutions with Almac's IXRS(R)
technology, an integrated phone and web platform. This unique industry
offering will allow patients to receive messages for key elements of their
required study conduct using Short Message Service (SMS) text messages,
emails, or phone calls. Examples of messages include reminders to attend
clinic visits or to fill out patient diaries, medication prompts, notices to
attend appointments in a fasted state, to return unused medication, and even
encouragement messages to keep all patients motivated to participate in the
clinical trial.

The Almac-Exco InTouch alliance offers sponsors the benefit of
alleviating clinical trial site personnel of significant administrative
burdens and activities relating to protocol compliance. Moreover, it provides
biopharmaceutical firms a way to ease a patient's journey through the
clinical trial process using familiar technologies that are both popular and
ubiquitous, including phone, web, text messages and email. The solution keeps
patients on track during a trial and offers them an "electronic tap on the
shoulder" in their native languages to help drive compliance. As trials
become increasingly more complex and global, the application of such
cost-effective technologies to drive compliance and enhance clinical trial
site productivity will serve a vital role in the drug development process.

Almac President Jim Murphy comments on the alliance with Exco InTouch:
"The alliance between Almac and Exco InTouch provides sponsors with a
practical, cost-effective solution to managing patients during a clinical
trial. Our joint solutions will help enhance patient recruitment, retention,
and compliance, three highly critical areas of concern for our clients."

Tim Davis, CEO of Exco InTouch describes the relationship as "the perfect
integration of complementary technology products, adding "we are delighted to
work with Almac's clinical technologies business on such a powerful mobile
and interactive response solution. Rarely do you have an opportunity to
employ a solution that will help all trial participants, the sponsor, the
site, and the patient. Our clients are already looking forward to taking
advantage of this unique Almac-Exco InTouch offering."

Almac and Exco will be featuring a demo of their integrated services at
the upcoming conferences - Euro DIA, March 28th to 30th and Partnerships in
Clinical Trials, March 30th to April 1st.

About Almac Group:

The Almac Group provides a broad range of services from R&D, biomarker
discovery and development, API manufacture, formulation development, clinical
trial supply and IXRS technology (IVRS/IWRS), to commercial-scale
manufacture. Almac provides services to more than 600 companies, including
all the world leaders in the pharmaceutical and biotech sectors.

The company employs over 3,000 individuals and is headquartered in
Craigavon, Northern Ireland. US operations are based in Pennsylvania, North
Carolina and California. Almac has now moved into its new $120m North
American Headquarters located in Souderton PA.

Almac's Clinical Technologies business unit specializes in interactive
technology and service solutions to increase the quality and efficiency of
clinical trials. Our solutions include Interactive Voice and Web Response
Systems (IXRS(R)) for patient randomization and drug assignment, patient and
clinical supplies management, electronic-patient-reported-outcomes data
collection, and Web drug reconciliation. Almac's technologies have been
deployed in over 1600 clinical trials, incorporating over 1.5 million
patients in over 80 countries, and more than 60 languages.

For more information about the Almac Group, please visit
www.almacgroup.com or e-mail info@almacgroup.com

About Exco InTouch:

Exco InTouch is the leading provider of interactive patient
communication solutions using internet and cell phone technology. Using a
combination of software and services, Exco InTouch offers BioPharma sponsors,
CROs and patient recruitment agencies the opportunity to improve patient
recruitment, retention and compliance using timely notifications, alerts and
two-way messages.

Additionally, Exco collects electronic patient reported
outcomes (ePRO) and diary data using standard cell phone technology which is
both cost effective for sponsors and extremely easy and convenient for trial
subjects. These solutions are currently being used by hundreds of thousands
of patients in over 70 countries, delivered in the local language and are
fully compliant with HIPAA regulations, FDA CFR 21 Part 11 and all electronic
communication privacy directives.

Contacts: Joseph Bedford, PhD, T: +1-215-660-8500, E: clinicaltechnologies at almacgroup.com; Tristan Jervis, De Facto, Tel: +44(0)207-861-3838, E: t.jervis at defacto.com